Edinburg Native, Dorinda Rodriguez Earns Doctorate in Occupational Therapy

Translate to Spanish or other 102 languages!

dorinda-rdz

- Advertisement -

Mega Doctor News – 

By Christine Ardis,

Edinburg native Dorinda Rodriguez, OTR, CHT, recently earned a doctorate in occupational therapy from Rocky Mountain University of Health Professionals in Provo, Utah.

- Advertisement -

Rodriguez earned a bachelor of science in occupational therapy from the University of Texas Health Science Center in San Antonio in 1996. Two years later, she graduated from the Hand Therapy Fellowship Program through Texas Woman’s University and the Hand and Upper Extremity Institute of the Baylor College of Medicine.  In 2001, Rodriguez became a certified hand therapist.

A Certified Hand Therapist (CHT) is an occupational therapist or physical therapist who has a minimum of five years of clinical experience, including 4,000 hours or more in direct practice in hand therapy. In addition, the Certified Hand Therapist has successfully passed a rigorous exam covering advanced clinical skills and theory in upper quarter rehabilitation.

Hand therapy is the art and science of rehabilitation of the upper limb, which includes the hand, wrist, elbow, and shoulder girdle. It is a merging of occupational and physical therapy theory and practice, combining comprehensive knowledge of the structure of the upper limb with function and activity. Using specialized skills in assessment, planning, and treatment, hand therapists provide therapeutic interventions to prevent dysfunction, restore function, and/or reverse the progression of pathology of the upper limb in order to enhance an individual’s ability to execute tasks and to participate fully in life situations.

Rodriguez has over 19 years of experience in the treatment of upper extremity musculoskeletal conditions and has owned a private practice in the Rio Grande Valley since 2000.  She currently owns and treats patients at RGV Hand Therapy Center in Edinburg.

- Advertisement -

The Doctor of Occupational Therapy Program (OTD) at Rocky Mountain University of Health Professionals is designed to teach evidence-based practice, leadership, and professional development to occupational therapists, inspiring them to become practice-scholars and leaders in health and human services.  The program is also committed to the development of occupational therapists who will integrate clinical expertise, the best evidence available from research, and the values and preferences of their patients in order to make the best healthcare decisions.

Rodriguez’s capstone project, The Occupational Therapist’s Role in Hand Therapy: A Collaborative Approach to Health Care Success, utilized evidenced-based research to support an inter-professional course designed to educate future healthcare professionals about the occupational therapist’s role in hand therapy.  This course also provides clinically relevant and evidence-based therapeutic interventions for common upper extremity musculoskeletal conditions, thus improving the efficiency and effectiveness of the occupational therapist’s treatment approach.  A clear understanding of all of the aspects of hand therapy will improve collaboration among healthcare providers, resulting in more successful functional outcomes for patients here in the Rio Grande Valley.

For more information or to speak with Dorinda Rodriguez, please call 956-661-9490. MDN

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -